Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Primary Central Nervous System Lymphoma (PCNSL) × ibrutinib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 CNS 1

Conditions

Glioblastoma 2 Brain Neoplasms 2 Primary Central Nervous System Lymphoma (PCNSL) 1 Neurologic Manifestations 1 Neuroectodermal Tumors, Primitive 1 Medulloblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

ibrutinib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07082868 2026-02-17

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting

Primary Central Nervous System Lymphoma (PCNSL)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡